Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Ketty Peris, Rodolfo Capizzi, Sara Tambone, Maria C. Fargnoli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

4 Citazioni (Scopus)

Abstract

In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
Stato di pubblicazionePubblicato - 2015

Keywords

  • actinic keratosis

Fingerprint Entra nei temi di ricerca di 'Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series'. Insieme formano una fingerprint unica.

Cita questo